-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Bionano Genomics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2017 to Q3 2024.
- Bionano Genomics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.2M, a 44.8% decline year-over-year.
- Bionano Genomics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $11.2M, a 35.4% decline year-over-year.
- Bionano Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $15.2M, a 32.3% decline from 2022.
- Bionano Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $22.4M, a 131% increase from 2021.
- Bionano Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.72M, a 525% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)